Inj. Hyperbaric Bupivacaine (0.5%) 17.5mg (3.5ml) + Preservative free Inj. Morphine Sulphate 100µg (0.1ml) intrathecaly to a total volume of 3.6ml Group B Inj. Hyperbaric Bupivacaine (0.5%) 17.5mg (3.5ml) + Inj. Normal saline (0.9%) 0.1ml intrathecaly to a total volume of 3.6ml
(p > 0.05).VAS score was higher in group B as compared to group M occurrence of any side effects.
at all time intervals except at 12th hours (p < 0.001), as by that time all patients in group B had already received rescue analgesia. In group M, 8 patients (20%) did not require analgesic on the day of surgery. The average duration of analgesia was 13.825 ± 4.206 hours A prospective randomized study The study was conducted on 80 in group M and 4.762 ± 0.679 hours in group B (p < 0.001).Total female patients in the age group of 18 to 60 years, belonging to ASA number of rescue analgesic doses required were significantly less in grade I to III scheduled for vaginal hysterectomy Patients were group M (1.225 ± 0.480 injections) as compared to group B (2.65 ± randomly divided in to two equal groups. 0.580 injections) (p < 0.001).Intra-operatively, bradycardia occurred in 17.5% of patients in group M and 2.5% of patients in Group B, it They received intrathecal drugs as follows.
was treated with inj atropine sulphate 0.6 mg intravenously. No In pre anaesthesia room, pulse rate, blood pressure and respiratory patient developed hypotension which required treatment. 37.5% rate were noted & patients were preloaded with 1litre of crystalloids patients in group M and 15% patients in group B developed nausea and premedicated with inj glycopyrrolate 0.004 mg/kg and inj and vomiting (p < 0.05). 37.5% patients in group M developed odansatron 4 mg intravenously.
pruritus while no patients in group B developed pruritus (p < 0.001).
No patients in any group developed respiratory depression. In operation theatre, lumbar puncture was performed under strict aseptic and antiseptic precaution in the lateral decubitus position at the level of L3-4 or L2-3 inter space using 23G or 25G number spinal needle. After ensuring free flow of CSF, study drug was injected. The We thus conclude that intrathecal administration of 0.1mg time of intrathecal injection was noted and immediately after it preservative free morphine along with 0.5% bupivacaine (17.5mg) patients were turned to supine. Baseline pulse rate, blood pressure, significantly prolongs the duration of post-operative analgesia up to respiratory rate and sedation score(ramsay scale) were recorded & 14 hours. It also reduces post-operative analgesic requirement in first monitored every 5 minutes up to 30 minutes, at 45 minutes, 60 24 hours. It leaves the patient calm, comfortable, minimally sedated minute, 90 minute, 120 minute, 150 minute, 3h, 4h, 5h, 6h, 9h, 12h though easily arousable during intraoperative and immediate post and at 24 hour. Visual analogue scale for pain was recorded at 1h, 2h, operative period without any serious adverse effects except vomiting 3h, 4h, 5h, 6h, 9h, 12h and at 24hrs. Sensory blockade was assessed and pruritus which is easily treatable. after injection of the drug to complete ablation of pinprick test. Motor blockade was assessed by bromage scale. Post-operatively rescue analgesia was supplemented with inj. diclofenac sodium 1.5 Intrathecal morphine, spinal anesthesia, vaginal hysterectomy. mg/kg intramuscularly when VAS score > 3. Patients were observed for side effects like hypotension, bradycardia, respiratory depression, nausea, vomiting, urinary retention and itching.
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